CKS2 and non-small cell lung carcinoma: Recently, CKS2 has been observed to exert oncogenic influence, showing high expression in various malignant tumors such as esophageal cancer (Zhang et al. 2020), cervical cancer (CC) (Qin et al. 2022), and non-small cell lung cancer (NSCLC) (Wan et al. 2022).